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Introduction: In epilepsy, the diagnosis of mild Malformation of Cortical Development type II (mMCD II) predominantly
relies on the histopathological assessment of heterotopic neurons in the white matter. The exact diagnostic criteria for
mMCD II are still ill-defined, mainly because findings from previous studies were contradictory due to small sample size,
and the use of different stains and quantitative systems. Advance in technology leading to the development of whole
slide imaging with high-throughput, automated quantitative analysis (WSA) may overcome these differences, and may
provide objective, rapid, and reliable quantitation of white matter neurons in epilepsy. This study quantified the density
of NeuN immunopositive neurons in the white matter of up to 142 epilepsy and control cases using WSA. Quantitative
data from WSA was compared to two other systems, semi-automated quantitation, and the widely accepted method of
stereology, to assess the reliability and quality of results from WSA.
Results: All quantitative systems showed a higher density of white matter neurons in epilepsy cases compared to
controls (P = 0.002). We found that, in particular, WSA with user-defined region of interest (manual) was superior in terms
of larger sampled size, ease of use, time consumption, and accuracy in region selection and cell recognition compared
to other methods. Using results from WSA manual, we proposed a threshold value for the classification of mMCD II,
where 78% of patients now classified with mMCD II were seizure-free at the second post-operatively follow up.
Conclusion: This study confirms the potential role of WSA in future quantitative diagnostic histology, especially for the
histopathological diagnosis of mMCD.
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According to the Palmini classification, the observation
of ‘excess’ heterotrophic neurons in layer I and the white
matter are classified as mild forms of Malformation of
Cortical Development (mMCD) type I and II respect-
ively [1]. There are presently no other criteria to aid the
assessment of mMCD II [2]. Despite many previous
studies in this field, the oldest dating back to 1984 [3], it
is still uncertain whether the density of WMN is in-
creased in patients with epilepsy, what the threshold for* Correspondence: m.thom@ucl.ac.uk
1Department of Clinical and Experimental Epilepsy, UCL Institute of
Neurology, Queen Square, WC1N 3BG London, UK
2Division of Neuropathology, National Hospital for Neurology and
Neurosurgery, Queen Square, WC1N 3BG London, UK
Full list of author information is available at the end of the article
© 2014 Liu et al.; licensee BioMed Central Ltd.
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.the diagnostic confirmation of mMCD II should be [2],
whether the severity of this pathological feature corre-
lates with pre-operative MRI, and represents a clinically
relevant, prognostic biomarker, in particular for outcome
following epilepsy surgery [4-8]. Findings from previous
quantitative studies have been contradictory [3,9-14],
due to the small sample size used (<52 cases), and differ-
ing counting methods, equipment, regions of analysis,
and cell types studied (Additional file 1: Table S1). Ex-
cess density of WMN has also been reported in patients
with schizophrenia and autism [15-19], suggesting the
possibility that the WMN density may be an indicator of
neurodevelopmental disorders beyond epilepsy. Conse-
quently, there is a clinical need for the accurate, rapid
evaluation of the numerical threshold of ‘excess’ WMNThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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between WMN density and epileptogenesis, pharma-
coresistance and surgical outcome.
Recent technological advances in quantitative hist-
ology, with systems such as whole slide imaging with
high-throughput, automated analysis (WSA), means that
it is now possible to more accurately and efficiently
quantify histological stains and immunolabelling, which
may aid the clinical diagnosis of a wide range of diseases
[20-24] and be instrumental in the design of persona-
lised treatment plans which may improve patients’
chances of recovery [25,26]. In fact, there is an increas-
ing official acceptance of WSA: the United States Food
and Drug Administration has approved the WSA of sev-
eral major companies for the diagnostic evaluation/
screening of HER2, PR, ER, Ki67 and/or p53 immunola-
belling (Additional file 2: Table S2), underlining the im-
portance and relevance that quantitative histopathology
has in personalised medicine. However, before such ad-
vanced system is used in routine clinical laboratory, it is
important to carefully compare the cost and applicabil-
ity, and validate the quality of results obtained against
traditionally used methods such as semi-automated ana-
lysis, and established, gold standard approaches for
quantifying the number of neurons in volume of tissue,
such as stereology [27].
As such, this study aims to quantify the density of
NeuN immunopositive neurons in the white matter of
up to 130 samples from patients with epilepsy who have
undergone a standardised surgical procedure (anterior
temporal lobectomy) for the same underlying pathology
(hippocampal sclerosis) and 12 controls using three
quantitative methods: (i) WSA, (ii) semi-automated ana-
lysis that processes pre-acquired images of the white
matter (SA), and (iii) stereology (n = 50 cases). This
highly homogenous group of epilepsy patients has com-
prehensive clinical data (Additional file 3: Table S3) to
allow us to investigate the clinical relevance of WMN
density in epilepsy. Quantification of WMN using the
three systems would also allow us to compare the quan-
titative results, ease of use, time consumption, reliability,
and accuracy in the selection of regions and identifica-
tion of cells.
Material and methods
This study was approved by the Joint Research Ethics
Committee of the National Hospital for Neurology and
Neurosurgery and the UCL Institute of Neurology. Pa-
tients had given consent to the use of their brain tissue
in research, and the tissue was used in accordance with
the current UK Human Tissue Authority guidelines. An-
terior temporal lobectomy specimens from 130 epilepsy
cases and 12 controls (five normal, post mortem con-
trols with no brain pathology, and seven non-epilepsy,surgical controls) were studied. In the epilepsy cases, the
resected sample was taken 1 to 1.5 cm from the tem-
poral pole and the sample included the superior, middle,
and inferior temporal gyrus with underlying white mat-
ter extending to the ventricle. The average age of cases
with epilepsy and non-epilepsy surgical controls was
37 years and 39 years respectively. Clinical details of
surgical epilepsy and control cases are summarised in
Additional file 3: Table S3. Seven to 20 μm-thick,
formalin-fixed, paraffin-embedded brain tissue sections
from each case were processed and immunolabelled
using the marker for mature neurons, Neuronal Nuclei
(NeuN, 1:100, Millipore MAB377, UK), and counterstain
with haematoxylin (VWR International, UK). The exact
section thickness of each case (or the depth of field ‘z’
reading) was later measured using the Zeiss Axio Imager
Z2 Motorised microscope with 63× objective lens (aver-
age actual thickness ± standard deviation, 17 μm± 5).
NeuN immunopositive cells in the white matter of each
sections were counted using (i) WSA: whole slide im-
aging with high-throughput, automated analytic (Tissue
Studio and Developer XD, Germany) with automated
and manual ROI selections, and (ii) SA: semi-automated
image analytic (ImageProPlus version 6.2, Media Cyber-
netics, USA), and (iii) three dimensional stereology
(Histometrix, Kinetic Imaging, UK).
For WSA, sections were initially scanned on a LEICA
SCN400F digital slide scanner (LEICA Microsystems,
Wetzlar, Germany). Scanned images were processed
into a Pyramid TIFF file, stored on a fileserver and
viewed and managed on the SlidePath Digital Image
Hub (LEICA). Analysis was carried out with Definiens
Tissue Studio 3.6 (Definiens AG Munich, Germany).
Prior to the study, a set of image analysis algorithms
(“solutions”) with specific parameters were tested and
optimised on Definiens Tissue Studio in a pilot study.
The optimised parameters were applied as follows
(Figure 1): First, tissue was selected from the background
of each scanned image by setting homogeneity to 2.1
units, brightness to 200 units, and tissue minimum size to
450 μm2. By setting the initialisation magnification to 0.4
units, each section was then segmented into geographical
regions based on the distribution of NeuN.
The images of 142 epilepsy and control cases were
categorised into groups or ‘classes’ with similar intensity
of haematoxylin staining and NeuN immunopositive
labelling so the same algorithm could be applied to all
sections of the same class; this would assist and speed
up the user-training process. During the user-training
process in WSA with automated ROI selection, the re-
searcher ‘trained’ the program to recognise the cerebral
cortex, grey/white matter border, white matter and empty
spaces by selecting a few segments of well-defined areas
within each region from two scanned images within each
Figure 1 Quantification of NeuN immunopositive neurons in the white matter. (A) A surgically-resected temporal lobe from a patient with
epilepsy who had undergone standard temporal lobectomy. (B) A 7μm-thick section was cut, immunolabelled using the neuronal marker, NeuN,
and scanned using the whole slide scanner (LEICA). Using WSA, the white matter was selected automatically or manually on digitised images of
NeuN immunopositive sections. In WSA automated, the programme identified the white matter by following a series of algorithms such as tissue
and background separation (C), and showed the training step, whereby the user selected ‘segments’ that were representative of the cortex
(orange) or white matter (yellow; D), and the programme learned to identify other ‘patches’ of similar features (E). (F) In WSA manual, the user
interactively outlined the white matter. After ROI selection, NeuN immunopositive cells in the white matter (G) of all cases were quantified by WSA
(H). (I) In SA, images (yellow) were manually acquired by the user and then fed into a semi-quantitative analysis programme for quantification. (J) For
stereology, a small area in the deep white matter was selected by the user and the programme moved through each point within the selection to
allow the user to count NeuN immunopositive cells at 63× magnification. Scale bar = 1 cm (A), 2 mm (B-F, I-J), 200 μm (G-H).
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rithms were applied to the grey/white matter boundary
where the interface between compartments was blurred.
Then the white matter was classified using the ‘nearest
neighbour’ option, and relative area of less than 0.1 unit.
These parameters/algorithms were then applied to all im-
ages in the same class.
For WSA with manual ROI selection, the researcher
outlined the white matter of each image using a styluspen on a touch-sensitive computer screen. This bound-
ary was drawn at a set distance of 0.5 mm from the cor-
tical margin, to exclude layer VI neurons. After either
manual or automated ROI selection, WSA identified and
counted NeuN immunopositive cells if labelled cells had
an intensity of 3.1 units. All counts were expressed as
cells per mm2 or mm3 adjusted by Abercrombie’s cor-
rection factor to correct for section thickness and mean
cell size [28]. Actual section thickness was measured on
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tion, and the cell size of NeuN immunopositive labelled
cells was measured using WSA. WSA also gave the per-
centage of NeuN immunopositive cells that were small
(area of <126.36 μm2), medium (126.36 – 370 μm2) or
large (>370 μm2).
For SA, 15 images of the white matter were pre-
acquired from each scanned image at 10× magnification.
NeuN immunopositive cells in each image were then
automatically selected by thresholding based on the in-
tensities in red, green, and blue channels.
49 epilepsy cases and one control were quantified using
stereological cell counting methods employed in our pre-
vious published studies [11,29,30]. The region of interest
in the deep white matter of each section was first outlined
at 2.5× objective on a the Zeiss Axioskop microscope
linked to a stereological software (Histometrix, Kinetic
Imaging, Nottingham, UK). All NeuN immunopositive
cells were counted with a 63× objective using the optical
dissector with uniform random field sampling, and a sam-
pling fraction of between 25–100% to minimise coefficient
of error to 0.1 unit or less where possible.
Nonparametric Kruskal-Wallis and post-hoc compari-
sons, Mann–Whitney, Spearman correlation, and intraclass
correlation coefficient tests were performed using SPSS 20
(IBM, USA). Correlations were conducted between density
of WMN and age, gender, length of seizure history, history
and frequency of simple partial seizures, generalised sei-
zures, secondary generalised seizures, and various post-
operative follow-ups (1st to 18th). To test the reliability of
each method, ten randomly-selected cases (two for stereol-
ogy) were re-analysed. Bland and Altman plots were pre-
sented, and Pearson’s correlation and intra-class correlation
coefficients using absolute agreement definition in a two-
way mixed model, and single measure were calculated.Figure 2 Cell identification using WSA automated and manual. (A) In
close to the grey/white matter demarcation (white arrow); some of these c
the user drew the white matter with a set distance away (0.5 mm) from th
confident that the counted cells were in the white matter.Results
The quantitative techniques and results from WSA were
compared with two other quantitative systems, SA, and
stereology.
Area of white matter quantified
The area of white matter sampled in 142 cases was sig-
nificantly different between WSA automated and man-
ual, SA and stereology (P < 0.000), but not between SA
and stereology (P = 0.06). The range and average area
sampled were the highest using WSA automated (246.1-
6.4 mm2, 74.3 mm2), followed by WSA manual (178.8-
3.4 mm2, 46.7 mm2), SA (7.1-0.4 mm2, 5.0 mm2) and
stereology (11.9-1.2, 4.0 mm2) respectively; this is ex-
pected since the WSA allows the entire white matter to
be sampled (Figure 1).
ROI selection and identification of neurons
For the quantification of WMN, the ability of the quantita-
tive systems to exclude neurons in the highly-populated
cortical Layer VI at the cortical/white matter demarcation
from the overall WMN counts is important. In stereology,
SA and WSA manual, the user manually outlined a ROI
that was clearly away from the cortex/white matter demar-
cation, so we could be confident that only neurons in the
white matter were selected (Figure 2). In WSA automated,
the program was trained to exclude areas in the cerebral
cortex and the grey/white matter border, and only to
quantify WMN within the white matter (Figure 2). When
we reviewed the screenshot images of the counted cells
for quality control purposes, we found that WSA auto-
mated correctly identified and quantified WMN in most
cases; there were only a few occasions where WSA auto-
mated included some neurons from the lower limits of
Layer VI.some cases, WSA automated quantified NeuN immunopositive cells
ells might be neurons in the cortical layer VI. (B) In contrast, because
e grey/white matter demarcation in WSA manual, we could be
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labelled, and they were distinct from the background, so it
was easy to train WSA and SA to accurately recognise and
count these cells, and for the user to identify immunoposi-
tive cells in stereology using a 63× objective.
Reliability of methods
Ten randomly selected cases in the series (and two cases
for stereology) were re-analysed to determine the reli-
ability of each method. No significant difference in
density values was observed between test and re-test
(P > 0.05) and the Pearson correlation coefficient (r) and
the intraclass correlation coefficient (ICC), which are
common measures of reliability [31], were above 0.6 for
all methods (Figure 3A). Past studies indicate that the
closer ICC and r are to one, the more reliable the
method [31]. In our study, WSA manual had a Pearson’s
correlation and an ICC value closest to one, suggesting
that this method was the most reliable compared to
other methods (Figure 3A-B). Bland and Altman plots
also support these findings by showing good agreementFigure 3 Measure of reliability. Ten cases (and two cases for stereology)
correlation coefficient (r), intraclass correlation coefficients (ICC) with 95% c
methods. The 95% level of agreement’s upper and lower boundary values
showing the correlation (left) and Bland & Altman plots (right) of WMN den
showing the time spent on each method. *see Eriksson et al. [29].with differences in most cases between test and retest
values lying near zero (Figure 3B).
Time consumption and ease of use
It took an average of six hours per case to quantify
WMN using stereology [29] compared to 45 minutes
per case using SA, 15 and ten minutes per case using
WSA automated and manual respectively (Figure 3C).
We found that WSA and SA were easier to use than ste-
reology, with fewer steps involved.
Density of WMN
The WMN density of all cases, corrected with the Aber-
crombie principle, was significantly different between
WSA automated and WSA manual, SA, and stereology
(P < 0.000; Figure 4A), but not between WSA manual and
SA (P = 0.07), WSA manual and stereology (P = 0.130), or
SA and stereology (P = 0.880). For epilepsy cases, the cor-
rected WMN density was significantly different between
all quantitative methods (P < 0.000), but not between
methods when applied to controls (P = 0.269). The lack ofwere re-analysed using all methods. (A) Table showing Pearson’s
onfidence interval (CI), ANOVA, and non-parametric P values for all
(UB, LB) in Bland and Altman plots were also presented. (B) Graphs
sity values between test and retest using all methods. (C) Table
Figure 4 Density of WMN. (A) Boxplot showing quantitative results of all cases using WSA automated, WSA manual, SA and stereology.
Horizontal line within box =median; top of the box = 75th percentile; bottom of box = 25th percentile; whiskers = 1.5x height of the box or
maximum/minimum values. Tabulated results were expressed as cells/mm2 or cells/mm3 after Abercrombie’s correction ± standard error of
means (SE). (B) Boxplot showing significantly higher densities of WMN in epilepsy cases compared to controls using all methods. ^The methodology
in stereology was a 3D cell counting method, so correction factors were not applied.
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due to the small number of controls analysed, or because
methods were less dissimilar if there were fewer WMN in
the ROI. Subsequent post-hoc comparisons showed a sig-
nificant difference in the corrected WMN density in epi-
lepsy cases between WSA automated and WSA manual,
SA, and stereology (P < 0.000) but not between WSA
manual and SA (P = 0.073), WSA manual and stereology
(P = 0.834), or SA and stereology (P = 0.706). The percent-
ages of small, medium or large NeuN immunopositive
cells in epilepsy cases were not significantly different be-
tween WSA automated and manual (P > 0.05).
Comparison of WMN density between cases with epilepsy
and controls
Quantitation revealed a significantly higher corrected
density of WMN in up to 130 epilepsy cases compared
to up to 12 controls using WSA automated (P = 0.022;Figure 4B), WSA manual (P = 0.004) and SA (P = 0.036).
Only one control case was analysed using stereology and
statistical analysis was hence not performed. The max-
imum WMN density for epilepsy cases in each method
were two or three-fold higher than the maximum WMN
density for controls. The corrected density of WMN in
control and epilepsy cases did overlap but no control
case had over 2298 cells/mm3 using WSA automated.
Our controls included five post mortem, normal cases,
and seven surgical, non-epilepsy cases. Surgical tissue
from neurologically normal patients is by definition not
available. Therefore, we used as controls histologically
normal, surgically resected tissue from non-epileptic pa-
tients with traumatic brain injury or tumours. No signifi-
cant difference in WMN density was observed between
these groups of controls using WSA automated and man-
ual, and SA. The corrected WMN density was signifi-
cantly different between epilepsy cases and post mortem
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controls using WSA automated and manual selections, and
SA. We cannot exclude that subtle oedema or mild gliosis
in our surgical non-epilepsy controls may have influenced
the density and location of WMN neurons in these surgical
controls.
The area of white matter sampled, thickness, and aver-
age cell diameter were not significantly different between
epilepsy cases and controls using any of the methods
(P > 0.05). The percentages of small, medium, and large
NeuN immunopositive cells and their average intensity
measured by WSA automated were not significantly dif-
ferent between epilepsy cases and post mortem and sur-
gical controls (Additional file 4: Table S4).
No significant correlation between the corrected dens-
ity of WMN in epilepsy cases and clinical parameters
was observed after Bonferroni correction for multiple
comparison was applied at P < 0.002.
Discussion
This is the first study that has investigated and com-
pared the reliability, accuracy, the ease of use and time
consumption of three quantitative systems, WSA, SA,
and stereology. We found that WSA sampled larger re-
gions, performed faster analysis, and provided the most
reproducible results compared to other systems. Using
WSA, we found that a higher density of WMN in the
130 epilepsy cases compared to controls, but the density
of WMN in epilepsy cases did not correlate with clinical
parameters relating to seizure frequency or surgical
outcome.
With the introduction of many different systems for
quantitative histology, it is important that systems are
rigorously tested for both reliability and cost-effectiveness,
especially if results are to be used to assist in clinical
diagnosis. Consequently, we compared the quantitative
findings from three systems, employing three different
counting approaches; stereology, SA and WSA. Three-
dimension stereology or design-based stereology has been
long considered as the most accurate method to quantify
neurons in an ‘optically-defined volume of tissue’ [27]. Ste-
reology avoids the need to correct for variation in section
thickness and cell size of each case as established in the
Abercrombie principle [28,32], with confident, unbiased
live counting of neurons at high magnification using 63 or
100× objectives. However, stereology is time-consuming,
taking approximately six hours per case [29], compared to
ten to 15 minutes per case with a maximally automated
system such as WSA. Stereology is, therefore, impractical
in a diagnostic laboratory. Findings from this study suggest
that automated systems such as WSA may be a good alter-
native to stereology, considering that no significant differ-
ence in WMN density values was observed between
stereology and WSA manual, and the results obtainedfrom WSA manual were reproducible and reliable as evi-
dent in the intra-rater reliability coefficient tests. Further-
more, the WSA system is superior over stereology: WSA
has the power to examine a large area and it avoids user-
selected bias of only small areas of interest (for SA and
stereology) which may not be representative of the whole
sample; it can also quantify sections rapidly, thus allowing
for more cases and additional morphometric data to be
examined without adding extra time to the count data
(whereas in stereology, the use of the optical dissector
method to measure the size of each cell drastically in-
creases the analysis time). Together, these advantages sup-
port the use of WSA in quantitative histology.
Establishing an agreed numerical threshold based on
the density of WMN to aid the diagnosis of mMCD II in
humans is a fundamental aim for neuropathologists
working in epilepsy surgical centres [2]. This informa-
tion is lacking, however, mainly because previous studies
have used different stains, quantitative methods, and
type of specimens (see Additional file 1: Table S1; [33]).
Here, using WSA on a large series of cases with uniform
pathology, surgical procedure, standardised tissue pro-
cessing, staining and selection of anatomical compart-
ment, thus forming an optimal group of cases to address
this research question, we found that all techniques
showed a significant increase of WMN density in the
epilepsy cases compared to normal post mortem con-
trols, which was consistent with previous quantitative
studies (see Additional file 1: Table S1). We found that,
while the range of WMN density values from controls and
epilepsy cases did overlap (consistent with [9,11,34,35]),
we did not observe any control case with a corrected
WMN density of over 2298 cells/mm3 (WSA with auto-
mated selection) regardless of which quantitative method
was used. Previously, Blümcke et al. suggested that a
WMN density excess of 20 cells/mm2 might be used to
diagnosis mMCD II [33], but as we found that some of
our normal post mortem cases had over 20 cells/mm2 re-
gardless of quantitative methods, we propose a scale for
the certainty of the diagnosis based on results obtained
using WSA with manual selection (Figure 5). For the
quantitation of WMN, WSA with manual selection is
faster and more consistent and reliable in identifying
neurons in the white matter compared to the complete
automated selection; in the manual selection, the user
drew a selection that was a set distance from the grey/
white matter demarcation, therefore excluding the cor-
tical layer VI.
The cause of the increased WMN density in epilepsy
is unknown. The failure of neuronal migration, and/or
the elimination or de novo generation of WMN, as
either a cause or effect of seizures, have all been postulated
but remain to be proven. In regards to their influence
on epileptogenesis, previous studies on the functional
Figure 5 Proposed criteria for the classification of mMCD II in epilepsy. (A) This may be used as practical guidelines for neuropathologists
to diagnose mMCD II in the temporal cortical resections from patients with mTLE and hippocampal sclerosis. Values are based on the present
study which have used cortical resections (inclusive of the superior, middle, and inferior temporal gyrus that were 1–1.5 cm from pole), and
immunohistochemistry using anti-NeuN (Millipore MAB377, 1:100, overnight). (B) In this study, WMN density values obtained using WSA manual,
whereby the area of interest was outlined a set distance (0.5 mm) from the grey-white matter boundary, was regarded as the gold standard in the
evaluation of neuronal counts. A graphical representation of our proposed numerical thresholds is presented here. Each point represents one case.
WSA =whole slide imaging with automated analysis, control max = the highest WMN density value from controls, control mean =mean WMN density
of controls, mMCD=mild Malformation of Cortical Development, SA = semi-automated analysis, sd = standard deviation, WMN =white matter neurons.
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conflicting [5,18,36-40]. Three studies have reported that
WMN density may have a predictive effect on seizure out-
come following surgical resection which would support a
role of increased WMN density in seizure networks in the
temporal lobe [9,11,14], but this finding was not observed
in other similar studies [10].
Conclusion
This study showed that WSA, a modern high-throughput,
automated analysis is more efficient in selecting larger re-
gions and cells of interest, and in processing cell counts
and morphometric data compared to the other systems.
These obvious advantages of whole slide scanning have to
be balanced with the practicalities and expense in that notevery neuropathology laboratory currently has access to
slide scanners and a whole slide image analysis software
solution. Furthermore, users should be reminded that
both WSA and SA rely on user-defined size and/or
thresholding parameters to identify cells of interest, so
the accuracy of quantification will ultimately be
dependent on the users’ settings and the quality of the
acquired images/scans. Therefore, quality assurance by
trained personnel after defining the parameters and re-
peated counts will be important. Nevertheless, the high-
throughput data generated with the WSA systems can
be used as a ‘gold standard’ to provide bench-mark cri-
teria (Figure 5) to translate into diagnostic practice
using a conventional microscope for the future assess-
ment of mild MCDs.
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Additional file 1: Table S1. Previous studies that have investigated
WMN in adult patients with epilepsy. H&E, Haematoxylin & Eosin; LFB-PAS,
Luxol Fast Blue- Periodic Acid Schiff; Map2, microtubule associated protein
2; NeuN, neuronal nuclei antigen; ROI, region of interest.
Additional file 2: Table S2. The US Food and Drug Administration has
approved the digital whole slide imaging hardware and analytic algorithms
of the above companies for the diagnostic evaluation or screening of HER2,
PR, ER, Ki67 and/or p53 (Digital Pathology Associations).
Additional file 3: Table S3. Summary of clinical details from patients
with epilepsy and non-epilepsy surgical controls. *Surgical outcome was
classified according to International League against epilepsy (ILAE, Wieser
et al. [41]) where 1 = completely seizure free and no aura; 2 = only auras
and no other seizures; 3 = one to three seizures days per year with/out
auras; 4 = four seizures days per year to 50% reduction of baseline seizure
days with/out auras; 5 = less than 50% reduction of baseline seizure days
to 100% increase of baseline seizure days with/out auras; 6 = more than
100% increase of baseline seizure days with/out auras; na = unknown.
sd = standard deviation.
Additional file 4: Table S4. Size and intensity of NeuN immunopositive
cells measured using WSA automated. The percentage of NeuN immunopositive
cells with an area of less than 126.36 μm2 (small), between 126.36-370 μm2
(medium) and over 370 μm2 (large) were not significantly different between
epilepsy and control cases.Abbreviations
WSA: Whole slide imaging with automated analysis; ICC: Intraclass
correlation coefficient; mMCD: mild Malformation of Cortical Development;
MRI: Magnetic resonance imaging; NeuN: Neuronal nuclei; ROI: Region of
interest; SA: Semi-automated analysis; WMN: White matter neurons.Competing interests
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